Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma.

ABSTRACT:

SUBMITTER: Broijl A 

PROVIDER: S-EPMC5004394 | biostudies-literature | 2016 Apr

REPOSITORIES: biostudies-literature